Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biologic Medication in COVID-19 Market Growth (Status and Outlook) 2022-2028

  • LP 4813623
  • 102 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biologic Medication in COVID-19 will have significant change from previous year. According to our (LP Information) latest study, the global Biologic Medication in COVID-19 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biologic Medication in COVID-19 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Biologic Medication in COVID-19 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biologic Medication in COVID-19 market, reaching US$ million by the year 2028. As for the Europe Biologic Medication in COVID-19 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biologic Medication in COVID-19 players cover Roche, Sanofi, Novartis, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Medication in COVID-19 market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Neutralizing Antibodies

Anti-inflammatory Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

COVID-19

Influenza

Malaria

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche

Sanofi

Novartis

Merck

Bayer

Shutaishen

Biogen

Regeneron Pharmaceuticals

Vir Biotech

Junshi Biosciences

Anke Biotechnology

OncoImmune

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biologic Medication in COVID-19 Market Size 2017-2028

2.1.2 Biologic Medication in COVID-19 Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Biologic Medication in COVID-19 Segment by Type

2.2.1 Neutralizing Antibodies

2.2.2 Anti-inflammatory Drugs

2.3 Biologic Medication in COVID-19 Market Size by Type

2.3.1 Biologic Medication in COVID-19 Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

2.4 Biologic Medication in COVID-19 Segment by Application

2.4.1 COVID-19

2.4.2 Influenza

2.4.3 Malaria

2.4.4 Others

2.5 Biologic Medication in COVID-19 Market Size by Application

2.5.1 Biologic Medication in COVID-19 Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

3 Biologic Medication in COVID-19 Market Size by Player

3.1 Biologic Medication in COVID-19 Market Size Market Share by Players

3.1.1 Global Biologic Medication in COVID-19 Revenue by Players (2020-2022)

3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2020-2022)

3.2 Global Biologic Medication in COVID-19 Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Biologic Medication in COVID-19 by Regions

4.1 Biologic Medication in COVID-19 Market Size by Regions (2017-2022)

4.2 Americas Biologic Medication in COVID-19 Market Size Growth (2017-2022)

4.3 APAC Biologic Medication in COVID-19 Market Size Growth (2017-2022)

4.4 Europe Biologic Medication in COVID-19 Market Size Growth (2017-2022)

4.5 Middle East & Africa Biologic Medication in COVID-19 Market Size Growth (2017-2022)

5 Americas

5.1 Americas Biologic Medication in COVID-19 Market Size by Country (2017-2022)

5.2 Americas Biologic Medication in COVID-19 Market Size by Type (2017-2022)

5.3 Americas Biologic Medication in COVID-19 Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biologic Medication in COVID-19 Market Size by Region (2017-2022)

6.2 APAC Biologic Medication in COVID-19 Market Size by Type (2017-2022)

6.3 APAC Biologic Medication in COVID-19 Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biologic Medication in COVID-19 by Country (2017-2022)

7.2 Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022)

7.3 Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biologic Medication in COVID-19 by Region (2017-2022)

8.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022)

8.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Biologic Medication in COVID-19 Market Forecast

10.1 Global Biologic Medication in COVID-19 Forecast by Regions (2023-2028)

10.1.1 Global Biologic Medication in COVID-19 Forecast by Regions (2023-2028)

10.1.2 Americas Biologic Medication in COVID-19 Forecast

10.1.3 APAC Biologic Medication in COVID-19 Forecast

10.1.4 Europe Biologic Medication in COVID-19 Forecast

10.1.5 Middle East & Africa Biologic Medication in COVID-19 Forecast

10.2 Americas Biologic Medication in COVID-19 Forecast by Country (2023-2028)

10.2.1 United States Biologic Medication in COVID-19 Market Forecast

10.2.2 Canada Biologic Medication in COVID-19 Market Forecast

10.2.3 Mexico Biologic Medication in COVID-19 Market Forecast

10.2.4 Brazil Biologic Medication in COVID-19 Market Forecast

10.3 APAC Biologic Medication in COVID-19 Forecast by Region (2023-2028)

10.3.1 China Biologic Medication in COVID-19 Market Forecast

10.3.2 Japan Biologic Medication in COVID-19 Market Forecast

10.3.3 Korea Biologic Medication in COVID-19 Market Forecast

10.3.4 Southeast Asia Biologic Medication in COVID-19 Market Forecast

10.3.5 India Biologic Medication in COVID-19 Market Forecast

10.3.6 Australia Biologic Medication in COVID-19 Market Forecast

10.4 Europe Biologic Medication in COVID-19 Forecast by Country (2023-2028)

10.4.1 Germany Biologic Medication in COVID-19 Market Forecast

10.4.2 France Biologic Medication in COVID-19 Market Forecast

10.4.3 UK Biologic Medication in COVID-19 Market Forecast

10.4.4 Italy Biologic Medication in COVID-19 Market Forecast

10.4.5 Russia Biologic Medication in COVID-19 Market Forecast

10.5 Middle East & Africa Biologic Medication in COVID-19 Forecast by Region (2023-2028)

10.5.1 Egypt Biologic Medication in COVID-19 Market Forecast

10.5.2 South Africa Biologic Medication in COVID-19 Market Forecast

10.5.3 Israel Biologic Medication in COVID-19 Market Forecast

10.5.4 Turkey Biologic Medication in COVID-19 Market Forecast

10.5.5 GCC Countries Biologic Medication in COVID-19 Market Forecast

10.6 Global Biologic Medication in COVID-19 Forecast by Type (2023-2028)

10.7 Global Biologic Medication in COVID-19 Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Biologic Medication in COVID-19 Product Offered

11.1.3 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Biologic Medication in COVID-19 Product Offered

11.2.3 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Biologic Medication in COVID-19 Product Offered

11.3.3 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Merck

11.4.1 Merck Company Information

11.4.2 Merck Biologic Medication in COVID-19 Product Offered

11.4.3 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck Main Business Overview

11.4.5 Merck Latest Developments

11.5 Bayer

11.5.1 Bayer Company Information

11.5.2 Bayer Biologic Medication in COVID-19 Product Offered

11.5.3 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bayer Main Business Overview

11.5.5 Bayer Latest Developments

11.6 Shutaishen

11.6.1 Shutaishen Company Information

11.6.2 Shutaishen Biologic Medication in COVID-19 Product Offered

11.6.3 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Shutaishen Main Business Overview

11.6.5 Shutaishen Latest Developments

11.7 Biogen

11.7.1 Biogen Company Information

11.7.2 Biogen Biologic Medication in COVID-19 Product Offered

11.7.3 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Biogen Main Business Overview

11.7.5 Biogen Latest Developments

11.8 Regeneron Pharmaceuticals

11.8.1 Regeneron Pharmaceuticals Company Information

11.8.2 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered

11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Regeneron Pharmaceuticals Main Business Overview

11.8.5 Regeneron Pharmaceuticals Latest Developments

11.9 Vir Biotech

11.9.1 Vir Biotech Company Information

11.9.2 Vir Biotech Biologic Medication in COVID-19 Product Offered

11.9.3 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Vir Biotech Main Business Overview

11.9.5 Vir Biotech Latest Developments

11.10 Junshi Biosciences

11.10.1 Junshi Biosciences Company Information

11.10.2 Junshi Biosciences Biologic Medication in COVID-19 Product Offered

11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Junshi Biosciences Main Business Overview

11.10.5 Junshi Biosciences Latest Developments

11.11 Anke Biotechnology

11.11.1 Anke Biotechnology Company Information

11.11.2 Anke Biotechnology Biologic Medication in COVID-19 Product Offered

11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Anke Biotechnology Main Business Overview

11.11.5 Anke Biotechnology Latest Developments

11.12 OncoImmune

11.12.1 OncoImmune Company Information

11.12.2 OncoImmune Biologic Medication in COVID-19 Product Offered

11.12.3 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 OncoImmune Main Business Overview

11.12.5 OncoImmune Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Biologic Medication in COVID-19 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Neutralizing Antibodies

Table 3. Major Players of Anti-inflammatory Drugs

Table 4. Biologic Medication in COVID-19 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Biologic Medication in COVID-19 Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

Table 7. Biologic Medication in COVID-19 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Biologic Medication in COVID-19 Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

Table 10. Global Biologic Medication in COVID-19 Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Biologic Medication in COVID-19 Revenue Market Share by Player (2020-2022)

Table 12. Biologic Medication in COVID-19 Key Players Head office and Products Offered

Table 13. Biologic Medication in COVID-19 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Biologic Medication in COVID-19 Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2017-2022)

Table 18. Americas Biologic Medication in COVID-19 Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Biologic Medication in COVID-19 Market Size Market Share by Country (2017-2022)

Table 20. Americas Biologic Medication in COVID-19 Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

Table 22. Americas Biologic Medication in COVID-19 Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

Table 24. APAC Biologic Medication in COVID-19 Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Biologic Medication in COVID-19 Market Size Market Share by Region (2017-2022)

Table 26. APAC Biologic Medication in COVID-19 Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

Table 28. APAC Biologic Medication in COVID-19 Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

Table 30. Europe Biologic Medication in COVID-19 Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Biologic Medication in COVID-19 Market Size Market Share by Country (2017-2022)

Table 32. Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

Table 34. Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Biologic Medication in COVID-19 Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Biologic Medication in COVID-19

Table 43. Key Market Challenges & Risks of Biologic Medication in COVID-19

Table 44. Key Industry Trends of Biologic Medication in COVID-19

Table 45. Global Biologic Medication in COVID-19 Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Biologic Medication in COVID-19 Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Biologic Medication in COVID-19 Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Application (2023-2028)

Table 51. Roche Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 52. Roche Biologic Medication in COVID-19 Product Offered

Table 53. Roche Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Roche Main Business

Table 55. Roche Latest Developments

Table 56. Sanofi Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 57. Sanofi Biologic Medication in COVID-19 Product Offered

Table 58. Sanofi Main Business

Table 59. Sanofi Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Sanofi Latest Developments

Table 61. Novartis Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 62. Novartis Biologic Medication in COVID-19 Product Offered

Table 63. Novartis Main Business

Table 64. Novartis Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Novartis Latest Developments

Table 66. Merck Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 67. Merck Biologic Medication in COVID-19 Product Offered

Table 68. Merck Main Business

Table 69. Merck Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Merck Latest Developments

Table 71. Bayer Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 72. Bayer Biologic Medication in COVID-19 Product Offered

Table 73. Bayer Main Business

Table 74. Bayer Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Bayer Latest Developments

Table 76. Shutaishen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 77. Shutaishen Biologic Medication in COVID-19 Product Offered

Table 78. Shutaishen Main Business

Table 79. Shutaishen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Shutaishen Latest Developments

Table 81. Biogen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 82. Biogen Biologic Medication in COVID-19 Product Offered

Table 83. Biogen Main Business

Table 84. Biogen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Biogen Latest Developments

Table 86. Regeneron Pharmaceuticals Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 87. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered

Table 88. Regeneron Pharmaceuticals Main Business

Table 89. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Regeneron Pharmaceuticals Latest Developments

Table 91. Vir Biotech Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 92. Vir Biotech Biologic Medication in COVID-19 Product Offered

Table 93. Vir Biotech Main Business

Table 94. Vir Biotech Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Vir Biotech Latest Developments

Table 96. Junshi Biosciences Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 97. Junshi Biosciences Biologic Medication in COVID-19 Product Offered

Table 98. Junshi Biosciences Main Business

Table 99. Junshi Biosciences Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Junshi Biosciences Latest Developments

Table 101. Anke Biotechnology Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 102. Anke Biotechnology Biologic Medication in COVID-19 Product Offered

Table 103. Anke Biotechnology Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Anke Biotechnology Main Business

Table 105. Anke Biotechnology Latest Developments

Table 106. OncoImmune Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors

Table 107. OncoImmune Biologic Medication in COVID-19 Product Offered

Table 108. OncoImmune Main Business

Table 109. OncoImmune Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. OncoImmune Latest Developments

List of Figures

Figure 1. Biologic Medication in COVID-19 Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Biologic Medication in COVID-19 Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Biologic Medication in COVID-19 Market Size Market Share by Type in 2021

Figure 7. Biologic Medication in COVID-19 in COVID-19

Figure 8. Global Biologic Medication in COVID-19 Market: COVID-19 (2017-2022) & ($ Millions)

Figure 9. Biologic Medication in COVID-19 in Influenza

Figure 10. Global Biologic Medication in COVID-19 Market: Influenza (2017-2022) & ($ Millions)

Figure 11. Biologic Medication in COVID-19 in Malaria

Figure 12. Global Biologic Medication in COVID-19 Market: Malaria (2017-2022) & ($ Millions)

Figure 13. Biologic Medication in COVID-19 in Others

Figure 14. Global Biologic Medication in COVID-19 Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Biologic Medication in COVID-19 Market Size Market Share by Application in 2021

Figure 16. Global Biologic Medication in COVID-19 Revenue Market Share by Player in 2021

Figure 17. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Biologic Medication in COVID-19 Market Size 2017-2022 ($ Millions)

Figure 19. APAC Biologic Medication in COVID-19 Market Size 2017-2022 ($ Millions)

Figure 20. Europe Biologic Medication in COVID-19 Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Biologic Medication in COVID-19 Market Size 2017-2022 ($ Millions)

Figure 22. Americas Biologic Medication in COVID-19 Value Market Share by Country in 2021

Figure 23. Americas Biologic Medication in COVID-19 Consumption Market Share by Type in 2021

Figure 24. Americas Biologic Medication in COVID-19 Market Size Market Share by Application in 2021

Figure 25. United States Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Biologic Medication in COVID-19 Market Size Market Share by Region in 2021

Figure 30. APAC Biologic Medication in COVID-19 Market Size Market Share by Application in 2021

Figure 31. China Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Biologic Medication in COVID-19 Market Size Market Share by Country in 2021

Figure 38. Europe Biologic Medication in COVID-19 Market Size Market Share by Type in 2021

Figure 39. Europe Biologic Medication in COVID-19 Market Size Market Share by Application in 2021

Figure 40. Germany Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application in 2021

Figure 48. Egypt Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Biologic Medication in COVID-19 Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 54. APAC Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 55. Europe Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 57. United States Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 58. Canada Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 61. China Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 62. Japan Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 63. Korea Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 65. India Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 66. Australia Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 67. Germany Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 68. France Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 69. UK Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 70. Italy Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 71. Russia Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 72. Spain Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 75. Israel Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Biologic Medication in COVID-19 Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390